Navigation Links
New study finds no benefit to selecting dose of blood thinner based on patients' genetic makeup
Date:11/19/2013

ectiveness. In 2007 and 2010, the FDA worked with the makers of warfarin drug products to modify the product label to indicate that a patient's genetic makeup may affect how he or she responds to the drug and that genetic information might be useful in determining the optimal starting dose.

To find out whether these genes could help clinicians prescribe an optimal dose, the Clarification of Optimal Anticoagulation through Genetics (COAG) trial consisting of 18 clinical sites across the country and funded by the National Heart, Lung and Blood Institute (NHLBI) tested two approaches for determining the best initial dose of warfarin in patients who were expected to need therapy for at least one month or longer by clinical information alone or by clinical information plus specific genetic information. The four-year study included 1,015 patients randomly assigned to one of two groups during the first five days of initiating warfarin therapy.

For the patients in the clinical-based dosing group, the initial warfarin dose was determined using step-by-step procedures based only on information about clinical factors, such as age, sex, weight, ethnicity, and the use of other medications. In the gene-based dosing group, the initial dose was determined using this same clinical information as well as information about the patient's genetic makeup, including analyzing the participants' DNA for the CYP2C9 and VKORC1 genes. Patients and their providers were blinded to the dose of warfarin for the first month of therapy.

The researchers found that there was no difference among the two groups in mean percentage of time in therapeutic range (PTTR) for the medication (45.2 percent in the pharmacogenetic-dosing group versus 45.4 percent in the clinical-guided dosing group) at four-weeks. There was, however, a statistically significant difference by race. Among African Americans, the mean PTTR for the pharmacogenetic-guided dosing group was less than that
'/>"/>

Contact: Jessica Mikulski
jessica.mikulski@uphs.upenn.edu
215-796-4829
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. New study reports on the high cost of cardiac surgery healthcare associated infections
2. New Study May Impact Practice Guidelines for Mitral Valve Surgery for Severe Ischemic Mitral Regurgitation
3. Study may impact guidelines for mitral valve surgery for severe ischemic mitral regurgitation
4. Advanced CT imaging proves as accurate as invasive tests to assess heart blockages, study shows
5. Chicago man breathes again thanks to Northwestern Medicine study
6. Study finds youth prefer and benefit more from rapid point-of-care HIV testing
7. Study: Ureteral injury during robot-assisted prostate surgery
8. Study: Odds of rehospitalization of cognitively impaired varies by discharge destination
9. A CNIO study recreates the history of life through the genome
10. Dr. Joe Dentistry Promotes Dental Exams as New Study Links Heart Disease to Oral Health
11. Study questions hypothermia treatment for cardiac arrest
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... New York (PRWEB) March 26, 2015 ... to move forward nationwide, with the issuance of ... in Pennsylvania and Louisiana. According to an Order ... multidistrict litigation established for Xarelto injury claims in ... will now allow plaintiffs to file cases directly ...
(Date:3/26/2015)... March 26, 2015 Behavioral Research ... firm, announced the release of BathroomMap® , a ... increase access to public restrooms for travelers, especially those ... apps, BathroomMap does not facilitate a paid, social or ... identify and rate local establishments that have clean, available ...
(Date:3/26/2015)... March 26, 2015 Saving Moses is ... it is most needed but least available. As one ... to six clinics in the Benguela province of Angola ... During a recent visit to their clinics, staff employed ... mothers and their babies in a nation the The ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 The ... 30th “Introduction to Hyperbaric Medicine” course, which is ... Society (UHMS) and the National Board of Diving ... the 40-hour course 4 times a year at ... the NY tri-state region; registration is available on-line ...
(Date:3/26/2015)... Springs, FL (PRWEB) March 26, 2015 ... of the nation’s leading innovative specialty pharmacies, announces ... created position of Vice President of Pharmaceutical Relations. ... fostering beneficial connections with our pharmaceuticals partners and ... relationships in support of BioPlus’ expansion. , ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, With Issuance of New Court Docs in State, Federal Litigations 3Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 2Health News:New Bathroom Finder App, BathroomMap®, Helps People with Medical Needs Who Urgently Need a Bathroom When Traveling 3Health News:Saving Moses Utilized Photography in an Effort to Engage Mothers and Their Babies on a Recent Visit to Angola 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 2Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 3Health News:The Life Support Technologies Group (LST) Conducted its 30th Accredited “Introduction to Hyperbaric Medicine” Course for Health Care Professionals 4Health News:BioPlus Specialty Pharmacy Expands Executive Team with New Position, Naming Sharon Ferrer as Vice President of Pharmaceutical Relations 2
... Getting details in writing would be ideal, survey finds , ... how long it takes to receive the results of radiology ... they do get the results, a U.S. study has found. ... X-ray. , "Most of the patients in our study were ...
... A patient,s socioeconomic status (income, martial status and race) ... radiation therapy for the treatment of prostate cancer, according ... Detroit. "This study offers an extremely ... receive radiation therapy," says Benjamin Movsas, M.D., senior study ...
... of Allergy and Infectious Diseases (NIAID), part of the ... to two programs that support research to better understand ... diseases, including those that may be introduced into a ... awarded to the Cooperative Centers for Translational Research on ...
... the H1N1 pandemic and West Nile virus -- as ... and environmental changes -- has prompted experts to look ... human, and environmental health. In turn, the nonprofit ... for improved collaboration across human, animal, and ecosystem health ...
... drowsy motorists, survey suggests , WEDNESDAY, Nov. 4 (HealthDay News) ... -- have had accidents or near-misses over the past year ... , Also, more than half of drivers surveyed admitted ... and 28 percent said they drive while sleepy at least ...
... , ... Future-focused performance management system prepares hospital leaders for the changing health care environment. ... ... extreme financial challenges—payment reform, reimbursement changes and a shift of patient services to ...
Cached Medicine News:Health News:Waiting, Wondering About Radiology Results Irks Patients 2Health News:Does race, income predict prostate cancer outcome? 2Health News:NIAID announces new human immunology research awards to help fight emerging infectious diseases 2Health News:NIAID announces new human immunology research awards to help fight emerging infectious diseases 3Health News:Sleepy Drivers a Menace on the Road 2Health News:Sg2 Announces Its INSIGHT System to Improve Hospitals' Clinical Performance and Bottom Line Results 2Health News:Sg2 Announces Its INSIGHT System to Improve Hospitals' Clinical Performance and Bottom Line Results 3
(Date:3/26/2015)... , March 26, 2015 ... please scroll to bottom . Investor-Edge has ... MYL ), Salix Pharmaceuticals Ltd (NASDAQ: SLXP ... (NASDAQ: VVUS ), and Akorn Inc. (NASDAQ: ... accessed at http://get.Investor-Edge.com/pdf/?c=Mylan&d=26-Mar-2015&s=MYL . The US markets declined ...
(Date:3/26/2015)... , Kalifornien, 26. März 2015 /PRNewswire/ ... Cellworld 2015, die sich speziell an Innovatoren, ... an. Die zweitägige Konferenz für ... September 2015 im Hyatt Regency in ... In diesem Forum werden führende Akteure der ...
(Date:3/26/2015)... 26 de março de 2015 A Finesse ... é projetado especificamente para os inovadores, visionários e executivos ... dias, apenas por convite, será realizada no Hyatt Regency ... 21 e 22 de setembro de 2015. Será um ... o futuro da fabricação de produtos biofarmacêuticos de uso ...
Breaking Medicine Technology:Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 2Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 3Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 4Active Equities to Watch in the Pharma Industry -- Mylan, Salix Pharma, Hospira, VIVUS, and Akorn 5Finesse Solutions kündigt Cellworld 2015 an 2Finesse Solutions anuncia Cellworld 2015 2
... Biopharmaceutical Services, Inc. announced today that the U.S. ... for an Electronic Submissions Gateway (ESG) to the ... clients a validated, direct electronic path for IND ... BLA (Biologic License Application) submissions and builds upon ...
... Gamma Knife® Perfexion™ earned the number one ranking in the ... in KLAS Awards: Medical Equipment & Infrastructure* report. Perfexion ... In the report, Perfexion scored 92.9 out of ... again. On a 1 to 9 scale, Perfexion received an ...
Cached Medicine Technology:Laureate's Electronic Submission Gateway Approved 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 2Elekta's Leksell Gamma Knife Perfexion is Ranked 2011's Best in KLAS for Radiation Therapy 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: